Clinical Trial Update: Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing raltegravir versus atazanavir, each combined with Truvada, in antiretroviral-naïve HIV-infected adults. Results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Emtricitabine/tenofovir disoproxil fumarate (Truvada) (emtricitabine/tenofovir disoproxil fumarate)
• Raltegravir (Isentress) (raltegravir)
• atazanavir (Reyataz) (atazanavir)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: HIV Infections | Phase 4 | Status: COMPLETED | Results posted: 2015-01-05